TY - JOUR
T1 - Idiopathic young-onset Fahr’s disease with schizophrenia-like presentation
T2 - a case report
AU - Li, Wen Cheng
AU - Hsieh, Ya Chu
AU - Chen, Pei Ting
AU - Lee, Chia Ning
AU - Tsai, Tsung Yu
N1 - Publisher Copyright:
Copyright © 2024 Li, Hsieh, Chen, Lee and Tsai.
PY - 2024
Y1 - 2024
N2 - This case report describes an exceptionally rare case in which a prior diagnosis of schizophrenia was later determined to be early-onset Fahr’s disease, linked to a genetic mutation in the SLC20A2 gene. Initially, the patient exhibited symptoms resembling schizophrenia, including aggression and hostility, and was highly susceptible to medication side effects such as restlessness and Parkinsonism. Despite maintaining independent activities of daily living, his neurological examinations revealed hidden weakness on the left side. Following adjustments to the medication regimen, stability was achieved with residual psychotic symptoms under treatment with Risperidone 1.5mg/day, Valproic acid 1500mg/day, and Quetiapine 37.5mg/day. This case underscores the importance of conducting comprehensive imaging studies at the time of initial psychiatric diagnosis, regardless of the apparent typicality of the presentation. Additionally, it emphasizes the need for patience and adherence to the “Start Low and Go Slow” approach in medication management to minimize the risk of exacerbating psychiatric symptoms and aggression.
AB - This case report describes an exceptionally rare case in which a prior diagnosis of schizophrenia was later determined to be early-onset Fahr’s disease, linked to a genetic mutation in the SLC20A2 gene. Initially, the patient exhibited symptoms resembling schizophrenia, including aggression and hostility, and was highly susceptible to medication side effects such as restlessness and Parkinsonism. Despite maintaining independent activities of daily living, his neurological examinations revealed hidden weakness on the left side. Following adjustments to the medication regimen, stability was achieved with residual psychotic symptoms under treatment with Risperidone 1.5mg/day, Valproic acid 1500mg/day, and Quetiapine 37.5mg/day. This case underscores the importance of conducting comprehensive imaging studies at the time of initial psychiatric diagnosis, regardless of the apparent typicality of the presentation. Additionally, it emphasizes the need for patience and adherence to the “Start Low and Go Slow” approach in medication management to minimize the risk of exacerbating psychiatric symptoms and aggression.
UR - http://www.scopus.com/inward/record.url?scp=85195103756&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85195103756&partnerID=8YFLogxK
U2 - 10.3389/fpsyt.2024.1391607
DO - 10.3389/fpsyt.2024.1391607
M3 - Article
AN - SCOPUS:85195103756
SN - 1664-0640
VL - 15
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 1391607
ER -